Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 21, 2016

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2025

Conditions
Prostate Cancer
Interventions
RADIATION

Stereotactic Body Radiation Therapy (SBRT) radiation for prostate cancer utilizing the Elekta Versa or Agility System.

SBRT uses advanced imaging techniques to deliver targeted radiation to a tumor. The Elekta Versa and Agility Systems are approved by the Food and Drug Association (FDA) for SBRT treatment of cancer.

Trial Locations (1)

92618

Hoag Memorial Hospital Presbyterian, Irvine

All Listed Sponsors
lead

Hoag Memorial Hospital Presbyterian

OTHER

NCT03889119 - Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer | Biotech Hunter | Biotech Hunter